Vasil Galat
Chief Executive & Scientific Officer ARTEC Biotech
Seminars
Wednesday 25th March 2026
Preclinical Characterization of NK Cells Derived from Pluripotent Stem Cells and Peripheral Blood
9:30 am
- Comparative analysis of NK cells derived from patient-matched induced pluripotent stem cells and peripheral blood to identify intrinsic phenotypic and metabolic differences
- Functional assessment of cytotoxicity and persistence to understand donor and source-dependent variability in NK cell performance
- Insights into how preclinical findings can guide optimization of cell sourcing, metabolic conditioning, and next-generation NK therapy design
